Clinical trials
Withdrawn Phase 2 Anemia trials
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
12 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2002 | 1 |
| 2005 | 1 |
| 2007 | 1 |
| 2015 | 1 |
| 2020 | 1 |
| 2021 | 1 |
| 2022 | 1 |
| 2025 | 2 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Withdrawn | 12 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| BioAge Labs, Inc. | 2 |
| Children's Hospital Medical Center, Cincinnati | 1 |
| Denver Health and Hospital Authority | 1 |
| Indiana University | 1 |
| Johnson & Johnson Pharmaceutical Research & Development, L.L.C. | 1 |
| Kezar Life Sciences, Inc. | 1 |
| M.D. Anderson Cancer Center | 1 |
| Ortho Biotech Products, L.P. | 1 |
| Regeneron Pharmaceuticals | 1 |
| University of California, San Francisco | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Anemia | 12 |
| Myelodysplastic Syndromes | 2 |
| Thrombocytopenia | 2 |
| Anemia, Hemolytic, Autoimmune | 1 |
| Anemia, Iron-Deficiency | 1 |
| Anemia, Sickle Cell | 1 |
| Arthritis, Rheumatoid | 1 |
| Blast Crisis | 1 |
| Burkitt Lymphoma | 1 |
| Congenital Abnormalities | 1 |
Trials
Showing 1 to 12 of 12. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.